Literature DB >> 21487512

Comparative analysis of NK-cell receptor expression and function across primate species: Perspective on antiviral defenses.

Roberto Biassoni1, Elisabetta Ugolotti, Andrea De Maria.   

Abstract

Natural killer (NK) cells are lymphoid effectors that are involved in the innate immune surveillance against infected and/or tumor cells. Their function is under the fine-tuning control of cell surface receptors that display either inhibitory or activating function and in healthy condition, mediate self-tolerance. It is known that inhibitory receptors are characterized by clonal and stochastic distribution and are extremely sensible to any modification, downregulation or loss of MHC class I surface expression that are induced in autologous cells upon viral infection or cancer transformation. This alteration of the MHC class I expression weakens the strength of the inhibitory receptor-induced interaction, thus resulting in a prompt triggering of NK cell function, which ends up in the inhibition of tumor progression and proliferation of pathogen-infected cells. Thus, the inhibitory function of NK cells is only one face of the coin, since NK-cell activation is controlled by different arrays of activating receptors that finally are involved in the induction of cytolysis and/or cytokine release. Interestingly, the inhibitory NK-cell receptors that are involved in dampening NK cell-mediated responses evolved during speciation in different, often structurally unrelated surface-expressed molecules, all using a conserved signaling pathway. In detail, during evolution, the inhibitory receptors that assure the recognition of MHC class I molecules, originate in, at least, three different ways. This ended up in multigene families showing marked structural divergences that coevolved in a convergent way with the availability of appropriate MHC ligand molecules.

Entities:  

Year:  2010        PMID: 21487512      PMCID: PMC3065668          DOI: 10.4161/self.1.2.11717

Source DB:  PubMed          Journal:  Self Nonself        ISSN: 1938-2030


  171 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D.

Authors:  Gopalakrishnan M Venkataraman; Dominic Suciu; Veronika Groh; Jeremy M Boss; Thomas Spies
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 3.  The Ly-49 family: genes, proteins and recognition of class I MHC.

Authors:  F Takei; J Brennan; D L Mager
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

4.  Molecular cloning and characterization of pig immunoreceptor DAP10 and NKG2D.

Authors:  D Yim; H B Jie; J Sotiriadis; Y S Kim; K S Kim; M F Rothschild; L L Lanier; Y B Kim
Journal:  Immunogenetics       Date:  2001-04       Impact factor: 2.846

5.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

6.  Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates.

Authors:  Jennifer G Sambrook; Arman Bashirova; Sophie Palmer; Sarah Sims; John Trowsdale; Laurent Abi-Rached; Peter Parham; Mary Carrington; Stephan Beck
Journal:  Genome Res       Date:  2005-01       Impact factor: 9.043

7.  Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors.

Authors:  Raja Rajalingam; Peter Parham; Laurent Abi-Rached
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

8.  Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

Authors:  J R Vidal-Castiñeira; A López-Vázquez; R Díaz-Peña; R Alonso-Arias; J Martínez-Borra; R Pérez; J Fernández-Suárez; S Melón; J Prieto; L Rodrigo; C López-Larrea
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

9.  Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes.

Authors:  Achim K Moesta; Laurent Abi-Rached; Paul J Norman; Peter Parham
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

10.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

View more
  4 in total

1.  High diversification of CD94 by alternative splicing in New World primates.

Authors:  John A Galindo; Luis F Cadavid
Journal:  Immunogenetics       Date:  2013-01-31       Impact factor: 2.846

2.  Natural killer cells in healthy and diseased subjects.

Authors:  Roberto Biassoni; John E Coligan; Lorenzo Moretta
Journal:  J Biomed Biotechnol       Date:  2011-08-29

3.  Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 control.

Authors:  Mauro S Malnati; Elisabetta Ugolotti; Maria Cristina Monti; Davide De Battista; Irene Vanni; Domenico Bordo; Francesca Sironi; Patrizia Larghero; Eddi Di Marco; Priscilla Biswas; Guido Poli; Elisa Vicenzi; Agostino Riva; Maciej Tarkowski; Giuseppe Tambussi; Silvia Nozza; Gino Tripodi; Francesco Marras; Andrea De Maria; Angela Pistorio; Roberto Biassoni
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

4.  SHP-1 phosphatase is a critical regulator in preventing natural killer cell self-killing.

Authors:  Sajid Mahmood; Namita Kanwar; Jimmy Tran; Man-Li Zhang; Sam K P Kung
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.